Skip to main content

MÉTODOS COMPUTACIONALES EN CRISTALOGRAFIA MACROMOLECULAR

BES-2015-076104

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Contratos Predoctorales
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae

  • Vizarraga, David
  • Mazzolini, Rocco
  • Lluch-Senar, Maria 1982-
  • Aparicio, David
Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections., This work was supported by grants BFU2018-101265-B-100 (MINECO) to I.F., BIO2017-84166-R (MINECO) to J.P., and BES-2015-076104 (MINECO) to M.L.S., JSPS KAKENHI Grant Number JP25000013 to K.N., and a FEDER project from Instituto de Salud Carlos III (ISCIII, Acción Estratégica en Salud 2016).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae

  • Vizarraga, David
  • Mazzolini, Rocco
  • Lluch-Senar, Maria 1982-
  • Aparicio, David
Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections., This work was supported by grants BFU2018-101265-B-100 (MINECO) to I.F., BIO2017-84166-R (MINECO) to J.P., and BES-2015-076104 (MINECO) to M.L.S., JSPS KAKENHI Grant Number JP25000013 to K.N., and a FEDER project from Instituto de Salud Carlos III (ISCIII, Acción Estratégica en Salud 2016).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae

  • Vizarraga, David|||0000-0002-4478-0155
  • Kawamoto, Akihiro|||0000-0002-7380-0127
  • Matsumoto, U.
  • Illanes, Ramiro|||0000-0002-1710-061X
  • Pérez-Luque, Rosa
  • Martín Sánchez, Jesús|||0000-0003-4250-4824
  • Mazzolini, Rocco|||0000-0003-3249-8387
  • Bierge, Paula|||0000-0003-0917-3445
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Espasa, Mateu|||0000-0003-4822-1024
  • Sanfeliu, Isabel
  • Esperalba, Juliana|||0000-0003-1326-1341
  • Fernández-Huerta, Miguel|||0000-0002-1733-0925
  • Scheffer, Margot P.
  • Pinyol Ribas, Jaume
  • Frangakis, Achilleas S.|||0000-0002-8067-6611
  • Lluch-Senar, Maria|||0000-0001-7568-4353
  • Mori, Shigetarou|||0000-0002-4880-410X
  • Shibayama, Keigo
  • Kenri, Tsuyoshi|||0000-0002-3198-4263
  • Kato, Takayuki|||0000-0002-8879-6685
  • Namba, Keiichi|||0000-0003-2911-5875
  • Fita, Ignacio|||0000-0002-7521-2679
  • Miyata, Makoto|||0000-0002-7478-7390
  • Aparicio Alarcón, David|||0000-0002-1971-5335
Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections.